Corydaline Inhibits Multiple Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes

doi:10.3390/molecules16086591

This article is

freely available
re-usable

Molecules 2011, 16(8), 6591-6602; doi:10.3390/molecules16086591

Article

Corydaline Inhibits Multiple Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes

Hye Young Ji^1,†, Kwang Hyeon Liu^2,†, Hyeri Lee^1,3, Sae Rom Im¹, Hyun Joo Shim⁴, Miwon Son⁴ and Hye Suk Lee^1,*

¹ Drug Metabolism and Bioanalysis Laboratory, College of Pharmacy, The Catholic University of Korea, Bucheon 420-743, Korea ² College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 702-701, Korea ³ Department of Agricultural Biotechnology, Seoul National University, Seoul 151-742, Korea ⁴ Research Center, Dong-A Pharmaceutical Co., Yongin 446-905, Korea ^† These authors contributed equally to this work.

* Author to whom correspondence should be addressed.

Received: 22 June 2011; in revised form: 27 July 2011 / Accepted: 2 August 2011 / Published: 5 August 2011

Download PDF Full-Text [574 KB, uploaded 5 August 2011 15:42 CEST]

Abstract: Corydaline is a bioactive alkaloid with various antiacetylcholinesterase, antiallergic, and antinociceptive activities found in the medicinal herb Corydalis Tubers. The inhibitory potential of corydaline on the activities of seven major human cytochrome P450 and four UDP-glucuronosyltransferase enzymes in human liver microsomes was investigated using LC-tandem MS. Corydaline was found to inhibit CYP2C19-catalyzed S-mephenytoin-4’-hydroxylatoin and CYP2C9-catalyzed diclofenac 4-hydroxylation, with K_i values of 1.7 and 7.0 mM, respectively. Corydaline also demonstrated moderate inhibition of UGT1A1-mediated 17b-estradiol 3-glucuronidation and UGT1A9-mediated propofol glucuronidation with K_i values of 57.6 and 37.3 mM, respectively. In the presence of corydaline, CYP3A-mediated midazolam hydroxylation showed a decrease with increasing preincubation time in a dose-dependent manner with K_i values of 30.0 mM. These in vitro results suggest that corydaline should be evaluated for potential pharmacokinetic drug interactions in vivo due to potent inhibition of CYP2C19 and CYP2C9.

Keywords: corydaline; cytochrome P450 inhibition; UDP-glucuronosyltransferase inhibition; human liver microsomes; drug-drug interaction

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Ji, H.Y.; Liu, K.H.; Lee, H.; Im, S.R.; Shim, H.J.; Son, M.; Lee, H.S. Corydaline Inhibits Multiple Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes. Molecules 2011, 16, 6591-6602.

AMA Style

Ji HY, Liu KH, Lee H, Im SR, Shim HJ, Son M, Lee HS. Corydaline Inhibits Multiple Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes. Molecules. 2011; 16(8):6591-6602.

Chicago/Turabian Style

Ji, Hye Young; Liu, Kwang Hyeon; Lee, Hyeri; Im, Sae Rom; Shim, Hyun Joo; Son, Miwon; Lee, Hye Suk. 2011. "Corydaline Inhibits Multiple Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes." Molecules 16, no. 8: 6591-6602.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert